PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Services, Cipla Ltd., Mumbai, India. dr.gupte@Cipla.com.\', \'Medical Services, Cipla Ltd., Mumbai, India.\', \'Head Clinical Research, Cipla Ltd., Mumbai, India.\', \'Drug Safety, Cipla Ltd., Mumbai, India.\', \'Medical Services, Clinical Trial Group, Cipla Ltd., Mumbai, India.\', \'Global Chief Medical Officer, Cipla Ltd., Mumbai, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-07004-8
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34983406
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all